EP2371357
Oral formulations and lipophilic salts of methylnaltrexone
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.3.2011EP published:
1.2.2017EP application number:
11157837.3
EPO information:
European Patent Register
Max expiry date:
10.3.2031
Title:
Oral formulations and lipophilic salts of methylnaltrexone
Timeline
Today
11.3.2011EP application
1.2.2017EP Publication
Owner
Name:
Wyeth LLCAddress:
235 East 42nd Street, 10017, New York, NY, US
Inventor
Name:
Shah, Syed M.Address:
East Hanover, NJ, US
Name:
Diorio, Christopher RichardAddress:
Campbell Hall, NY, US
Name:
Ehrnsperger, Eric C.Address:
New City, NY, US
Name:
Meng, XuAddress:
San Diego, CA, US
Name:
Shareffi, Kadum A.Address:
Congers, NY, US
Name:
Cohen, Jonathan MarcAddress:
Monroe, NY, US
Priority
Number:
313018 PDate:
11.3.2010Country:
US
Classification
Categories:
A61K 9/20, A61K 31/485, C07D 489/08